Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it
BackgroundLung adenocarcinoma patients are often found to have developed bone metastases at the time of initial diagnosis. With the continuous development of technology, we have successfully entered the era of immunotherapy. This study aimed to determine the efficacy of immunotherapy in lung adenoca...
Saved in:
Main Authors: | Zhangheng Huang, Yuexin Tong, Lujian Zhu, Binbin Yang, Kai Chen, Peiling Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1457916/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence and gender difference of brain metastases in newly diagnosed follicular thyroid cancer patients
by: Ruiguo Zhang, et al.
Published: (2024-12-01) -
Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments
by: Fatheia N. Hamza, et al.
Published: (2024-11-01) -
Development and validation of a prediction model for the prognosis of renal cell carcinoma with liver metastases: a population-based cohort study
by: Fei Wang, et al.
Published: (2024-12-01) -
Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
by: Yue Gong, et al.
Published: (2018-08-01) -
Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study
by: Martina Catalano, et al.
Published: (2025-02-01)